Ligand Reports First Quarter 2025 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 307.02 -15.73 (4.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $322.75 | 52 Week High | $139.79 | |||
| Open | $323.28 | 52 Week Low | $82.07 | |||
| Day High | $325.96 | P/E | 714.00 | |||
| Day Low | $306.17 | EPS | $0.43 | |||
| Volume | 265,435 | |||||
| (NASDAQ: VRNA) | Delayed: 106.91 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $106.91 | 52 Week High | $ | |||
| Open | $106.91 | 52 Week Low | $ | |||
| Day High | $106.91 | P/E | N/A | |||
| Day Low | $106.91 | EPS | $ | |||
| Volume | 171,186 | |||||
